Pharmaceutical research and discovery from Pharma Journal: target identification, preclinical science, drug-development platforms and the laboratories advancing new therapies. The science and strategy behind the industry's pipeline, for professionals across biotech, pharma and academia.
For over a century, the discovery of insulin transformed Type 1 Diabetes (T1D) from a fatal diagnosis into a survivable condition. Yet, despite remarkable technological advances, patients remain tethe
By Dr. Eleanor Vance, Regulatory Affairs Editor
The human immune system is a complex network of cells, tissues, and signaling molecules that serves as a defense system. It continuously identifies and eliminates viruses, bacteria, abnormal cells, an
By Dr. Eleanor Vance, Regulatory Affairs Editor
Chronic illness drives demand across the NHS and shapes budgets, workforce planning and service design. People living with multiple long-term conditions account for around half of hospital admissions,
By Dr. Eleanor Vance, Regulatory Affairs Editor
Antimicrobial resistance is accelerating across health systems and undermining routine care. Surgical prophylaxis, oncology regimens and neonatal medicine all depend on reliable antibiotics, yet resis
By Priya Raghavan, Biotech & Markets Analyst
For patients living with blood cancer or a severe blood disorder, a stem cell transplant is often the turning point between decline and recovery. Yet for years in the UK, the calendar has been the ene
By Dr. Eleanor Vance, Regulatory Affairs Editor
Human gene editing sits at a pivotal point in modern medicine. Its capacity to change DNA with precision has moved from conjecture to clinical practice, raising hopes for curative treatments while ign
By Dr. Eleanor Vance, Regulatory Affairs Editor
Gene therapy is moving from specialist promise to established practice in 2025. Approvals have broadened across indications, clinical data in Huntington's disease have shifted expectations for neurolo
By Dr. Eleanor Vance, Regulatory Affairs Editor
For acute pain, time matters. Patients with postoperative dental pain, primary dysmenorrhoea, tension-type headache or migraine want relief that begins quickly and remains reliable. Ibuprofen lysine,
By Dr. Eleanor Vance, Regulatory Affairs Editor
Calciphylaxis, also termed calcific uremic arteriolopathy, is uncommon yet catastrophic. Small and medium dermal arterioles mineralise and thrombose, tissue perfusion collapses, and exquisitely painfu
By Dr. Eleanor Vance, Regulatory Affairs Editor
Isopropyl alcohol (IPA) remains a critical solvent and intermediate in various industries, including healthcare, personal care, and electronics. Analyst estimates diverge on headline size, yet all sig
By Dr. Eleanor Vance, Regulatory Affairs Editor
A single figure can sway a submission or a clinical decision. When continuous data are grouped with unequal intervals, a simple count by bin exaggerates wide ranges and hides concentrated patterns. Th
By Priya Raghavan, Biotech & Markets Analyst
Huntington's disease remains without a cure in 2025. Clinical practice focuses on symptom control while a new wave of molecular programmes seeks to slow or halt neurodegeneration. The evidence base po
By Dr. Eleanor Vance, Regulatory Affairs Editor
Subscribe to our weekly pharmaceutical intelligence digest
We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy